Upgrade to SI Premium - Free Trial

Cowen Weighs in on Ardelyx, Inc (ARDX) FDA Briefing Documents

November 14, 2022 12:36 PM
Cowen analyst Joseph Thome weighed in on Ardelyx, Inc (NASDAQ: ARDX) following FDA briefing documents.The analyst commented, "Briefing docs were ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles